153 related articles for article (PubMed ID: 15882532)
1. In vitro pyrogenicity of the diphtheria, tetanus and acellular pertussis components of a trivalent vaccine.
Carlin G; Viitanen E
Vaccine; 2005 May; 23(28):3709-15. PubMed ID: 15882532
[TBL] [Abstract][Full Text] [Related]
2. In vitro pyrogenicity of Gram-positive bacteria--validation of the kit using fresh human whole blood.
François C; Neveu J; Sauvaire D; Bonnet PA; Tissier MH
Pharmeur Sci Notes; 2006 Aug; 2006(1):17-21. PubMed ID: 17694641
[TBL] [Abstract][Full Text] [Related]
3. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids.
Ryu YH; Baik JE; Yang JS; Kang SS; Im J; Yun CH; Kim DW; Lee K; Chung DK; Ju HR; Han SH
Int Immunopharmacol; 2009 Jan; 9(1):127-33. PubMed ID: 19013542
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between endotoxin and non-endotoxin pyrogens in human albumin solutions using an ex vivo whole blood culture assay.
Pool EJ; Johaar G; James S; Petersen I; Bouic P
J Immunoassay; 1999; 20(1-2):79-89. PubMed ID: 10225516
[TBL] [Abstract][Full Text] [Related]
5. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.
Geurtsen J; Banus HA; Gremmer ER; Ferguson H; de la Fonteyne-Blankestijn LJ; Vermeulen JP; Dormans JA; Tommassen J; van der Ley P; Mooi FR; Vandebriel RJ
Clin Vaccine Immunol; 2007 Jul; 14(7):821-9. PubMed ID: 17494641
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the reactivity of human and rabbit blood towards pyrogenic stimuli.
Schindler S; Bristow A; Cartmell T; Hartung T; Fennrich S
ALTEX; 2003; 20(2):59-63. PubMed ID: 12764541
[TBL] [Abstract][Full Text] [Related]
8. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
9. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
10. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
[TBL] [Abstract][Full Text] [Related]
11. Effect of moist heat sterilisation on the pyrogenicity of cell wall components from Staphylococcus aureus.
Moesby L; Timm M; Hansen EW
Eur J Pharm Sci; 2008 Dec; 35(5):442-6. PubMed ID: 18940250
[TBL] [Abstract][Full Text] [Related]
12. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide.
Kinsner A; Boveri M; Hareng L; Brown GC; Coecke S; Hartung T; Bal-Price A
J Neurochem; 2006 Oct; 99(2):596-607. PubMed ID: 16879708
[TBL] [Abstract][Full Text] [Related]
13. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.
McNeil SA; Noya F; Dionne M; Predy G; Meekison W; Ojah C; Ferro S; Mills EL; Langley JM; Halperin SA
Vaccine; 2007 Apr; 25(17):3464-74. PubMed ID: 17270320
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
Zepp F; Habermehl P; Knuf M; Mannhardt-Laakman W; Howe B; Friedland LR
Vaccine; 2007 Jul; 25(29):5248-52. PubMed ID: 17583395
[TBL] [Abstract][Full Text] [Related]
16. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
[TBL] [Abstract][Full Text] [Related]
17. The protein content of diphtheria-tetanus toxoids-acellular pertussis vaccines and an emerging clinical problem.
Cherry JD
J Infect Dis; 2005 Apr; 191(8):1386-8. PubMed ID: 15776394
[No Abstract] [Full Text] [Related]
18. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?
Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD
Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379
[TBL] [Abstract][Full Text] [Related]
19. Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.
Kikkert R; de Groot ER; Aarden LA
J Immunol Methods; 2008 Jul; 336(1):45-55. PubMed ID: 18456276
[TBL] [Abstract][Full Text] [Related]
20. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
Popescu C; Durbaca S; Ivanov D
Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
